New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor ...

Patient preference is an important part of cancer treatment planning, but new research suggests that many women facing ...

Read all the latest news headline updates on cancer drugs. Get all the cancer drugs breaking news updates, videos, photostories and more at Business Standard.

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received a successful response to its recent Type C meeting request from the U.S ...

There are many ways to create mental and physical separation from your work, including transition rituals, after-work routines, and mindfulness exercises. It can be easy to mentally carry your work ...

New findings have provided more evidence that omitting carboplatin from standard neoadjuvant therapy in HER2-positive early breast cancer can improve tolerability without compromising short-term ...

We’re outsourcing the very moments that create connection. Here’s how to be more intentional. by Amy Gallo “My coworker’s emails sound like a robot wrote them ...

Why did East Asia’s economy grow so rapidly in recent decades and Africa’s so slowly? How might Africa replicate East Asia’s success? A vast literature addresses these questions, but new books keep ...